Expression of Lrig1, a Negative Regulator of EGFR, Is Dynamically Altered During Different Stages of Gastric Carcinogenesis

American Journal of Pathology - United States
doi 10.1016/j.ajpath.2018.08.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

miR-141-3p Is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Serum Gastrin Levels in Different Stages of Distal Gastric Carcinogenesis: Is There a Role for Serum Gastrin in Tumor Growth?

Turkish Journal of Gastroenterology
Gastroenterology
2015English

Transcription Factor CUTL1 Is a Negative Regulator of Drug Resistance in Gastric Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Podoplanin Is a Negative Regulator of Th17 Inflammation

JCI insight
Medicine
2017English

RNase L Is a Negative Regulator of Cell Migration

Oncotarget
Oncology
2015English

Merlin Is a Negative Regulator of Human Melanoma Growth

PLoS ONE
Multidisciplinary
2012English

HSP70 Is a Negative Regulator of NLRP3 Inflammasome Activation

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer

Journal of Immunology
AllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy